This editorial discusses the new evidence coming to light that patients with HPV‐associated head and neck cancer are at increased risk of nutritional decline during treatment, with increased weight loss and higher need for tube feeding. Due to the anticipated epidemic of this particular disease, there is an ongoing need for research to ensure nutrition care outcomes and supportive care needs are optimised in this sub group, which will improve clinical outcomes and enhance patient quality of life.